This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignee: Transgene S.a.. Active years: 2012-2020.
Company Filing History:
Years Active: 2012-2020
Title: Innovations of Doris Schmitt
Introduction
Doris Schmitt is a notable inventor based in Plobsheim, France. She has made significant contributions to the field of medical research, particularly in the treatment of hepatitis B virus (HBV) infections. With a total of 4 patents to her name, her work has the potential to impact many lives.
Latest Patents
One of her latest patents focuses on a composition for treating HBV infection. This invention provides a composition comprising hepatitis B virus (HBV) component(s), which may be either nucleic acid- or polypeptide-based. It includes nucleic acid molecules and vectors encoding such HBV component(s). Additionally, it relates to infectious viral particles and host cells that comprise these nucleic acid molecules or vectors. The invention also provides compositions and kits of parts that include these nucleic acid molecules, vectors, infectious viral particles, or host cells, along with their therapeutic use for preventing or treating HBV infections.
Career Highlights
Doris Schmitt is currently associated with Transgene S.A., where she continues to innovate in the field of virology. Her work is characterized by a commitment to developing effective treatments for viral infections, showcasing her dedication to improving public health.
Collaborations
Doris has collaborated with several talented individuals, including Nathalie Silvestre and Perrine Martin. These collaborations have likely contributed to the advancement of her research and the successful development of her patents.
Conclusion
Doris Schmitt's contributions to the field of medical research, particularly in the treatment of HBV infections, highlight her role as an influential inventor. Her innovative work and collaborations continue to pave the way for advancements in healthcare.